The effectiveness of photobiomodulation therapy (PBMT) in modulation the gut microbiome dysbiosis related diseases
Gastroenterology and Hepatology from Bed to Bench,
Vol. 16 No. 4 (2023),
20 September 2023
https://doi.org/10.22037/ghfbb.v16i4.2687
Abstract
Maintaining a healthy balance between commensal, and pathogenic bacteria within the gut microbiota is crucial for ensuring the overall health, and well-being of the host. In fact, by affecting innate, and adaptive immune responses, the gut microbiome plays a key role in maintaining intestinal homeostasis and barrier integrity. Dysbiosis is the loss of beneficial microorganisms and the growth of potentially hazardous microorganisms in a microbial community, which has been linked to numerous diseases. As the primary inducer of circadian rhythm, light can influence the human intestinal microbiome. Photobiomodulation therapy (PBMT), which is the use of red (630-700 nm), and near-infrared light (700 and 1200 nm), can stimulate healing, relieve pain, and reduce inflammation, and affect the circadian rhythm and gut microbiome beneficially. Our focus in this paper is on the effects of PBMT on gut microbiota, to provide an overview of how it can help control gut microbiota dysbiosis-related disorders.
- gut microbiota, photobiomodulation, inflammation, dysbiosis
How to Cite
References
Durack J, Lynch SV. The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med 2019;216:20-40.
Yu-Ling T, Lin T-L, Chih-Jung C, Wu T-R, Wei-Fan L, Chia-Chen L, et al. Probiotics, prebiotics and amelioration of diseases. J Biomed Sci 2019;26.
Liang X, FitzGerald GA. Timing the microbes: the circadian rhythm of the gut microbiome. J Biol Rhythms. 2017;32:505-15.
Cui M, Xiao H, Luo D, Zhang X, Zhao S, Zheng Q, et al. Circadian rhythm shapes the gut microbiota affecting host radiosensitivity. Int J Mol Sci 2016;17:1786.
Thaiss CA, Levy M, Korem T, Dohnalová L, Shapiro H, Jaitin DA, et al. Microbiota diurnal rhythmicity programs host transcriptome oscillations. Cell 2016;167:1495-510.
Schmidt EK, Torres-Espin A, Raposo PJ, Madsen KL, Kigerl KA, Popovich PG, et al. Fecal transplant prevents gut dysbiosis and anxiety-like behaviour after spinal cord injury in rats. PloS One 2020;15:0226128.
Liebert A, Bicknell B, Johnstone DM, Gordon LC, Kiat H, Hamblin MR. “Photobiomics”: can light, including photobiomodulation, alter the microbiome? Photobiomodul Photomed Laser Surg 2019;37:681-93.
Bicknell B, Liebert A, Johnstone D, Kiat H. Photobiomodulation of the microbiome: implications for metabolic and inflammatory diseases. Lasers Med Sci 2019;34:317-27.
Liebert A, Bicknell B, Markman W, Kiat H. A potential role for photobiomodulation therapy in disease treatment and prevention in the era of COVID-19. Aging Dis 2020;11:1352.
Anders JJ, Lanzafame RJ, Arany PR. Low-level light/laser therapy versus photobiomodulation therapy. Photomed Laser Surg 2015;33:183-4.
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
Cresci GAM, Izzo K. Chapter 4 - Gut microbiome. In: Corrigan ML, Roberts K, Steiger E, editors. Adult Short Bowel Syndrome: Academic Press; 2019. p. 45-54.
Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Erratum: Enterotypes of the human gut microbiome. Nature 2011;474:666. Erratum in: Nature 2014;506:516.
Cunningham AL, Stephens JW, Harris DA. A review on gut microbiota: a central factor in the pathophysiology of obesity. Lipids Health Dis 2021;20:65.
Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell 2014;157:121-41.
Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, et al. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol 2016;22:501-18.
den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 2013;54:2325-40.
Jahani-Sherafat S, Azimirad M, Ghasemian-Safaei H, Amoli HA, Moghim S, Sherkat G, et al. The effect of intestinal microbiota metabolites on HT29 cell line using MTT method in patients with colorectal cancer. Gastroenterol Hepatol Bed Bench 2019;12:74.
Schulthess J, Pandey S, Capitani M, Rue-Albrecht KC, Arnold I, Franchini F, et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity 2019;50:432-45.
Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol 2020;11.
Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients 2011;3:858-76.
Im E, Riegler FM, Pothoulakis C, Rhee SH. Elevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice. Am J Physiol Gastrointest Liver Physiol 2012;303:490-7.
Sochocka M, Donskow-Łysoniewska K, Diniz BS, Kurpas D, Brzozowska E, Leszek J. The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer’s disease—a critical review. Mol Neurobiol 2019;56:1841-51.
Tracey KJ. The inflammatory reflex. Nature 2002;420:853-9.
El-Semman IE, Karlsson FH, Shoaie S, Nookaew I, Soliman TH, Nielsen J. Genome-scale metabolic reconstructions of Bifidobacterium adolescentis L2-32 and Faecalibacterium prausnitzii A2-165 and their interaction. BMC Sys Biol 2014;8:1-11.
Kim H, Jeong Y, Kang S, You HJ, Ji GE. Co-culture with Bifidobacterium catenulatum improves the growth, gut colonization, and butyrate production of Faecalibacterium prausnitzii: in vitro and in vivo studies. Microorganisms 2020;8:788.
Menees S, Chey W. The gut microbiome and irritable bowel syndrome. F1000Res. 2018;7:F1000 Faculty Rev-1029.
Shukla R, Ghoshal U, Ranjan P, Ghoshal UC. Expression of toll-like receptors, pro-, and anti-inflammatory cytokines in relation to gut microbiota in irritable bowel syndrome: the evidence for its micro-organic basis. J Neurogastroenterol Motil 2018;24:628.
Andrews CN, Sidani S, Marshall JK. Clinical management of the microbiome in irritable bowel syndrome. J Can Assoc Gastroenterol 2021;4:36-43.
Naseri K, Dabiri H, Rostami-Nejad M, Yadegar A, Houri H, Olfatifar M, et al. Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. BMC Gastroenterol 2021;21:1-14.
Soheilian-Khorzoghi M, Rezasoltani S, Moheb-Alian A, Yadegar A, Rostami-Nejad M, Azizmohammad-Looha M, et al. Impact of nutritional profile on gut microbiota diversity in patients with celiac disease. Curr Microbiol 2022;79:129.
Massier L, Blüher M, Kovacs P, Chakaroun RM. Impaired intestinal barrier and tissue bacteria: pathomechanisms for metabolic diseases. Front Endocrinol 2021;12:616506.
Chibbar R, Dieleman LA. The gut microbiota in celiac disease and probiotics. Nutrients 2019; 11:2375.
Losurdo G, Principi M, Iannone A, Ierardi E, Di Leo A. The interaction between celiac disease and intestinal microbiota. J Clin Gastroenterol 2016;50.
Galland L. The gut microbiome and the brain. J Med Food 2014;17:1261-72.
Martin CR, Osadchiy V, Kalani A, Mayer EA. The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol 2018;6:133-48.
Brown GC. The endotoxin hypothesis of neurodegeneration. J Neuroinflammation 2019;16:1-10.
Emanuele E, Orsi P, Boso M, Broglia D, Brondino N, Barale F, et al. Low-grade endotoxemia in patients with severe autism. Neuroscience let 2010;471:162-5.
Zhang R, Miller RG, Gascon R, Champion S, Katz J, Lancero M, et al. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol 2009;206:121-4.
Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, et al. Parkinson's disease: the emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation. J Neuroimmunol Motil 2019;25:363-76.
Hamblin MR. Shining light on the head: photobiomodulation for brain disorders. BBA Clin 2016;6:113-24.
Hamblin M. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics 2017;4:337-61.
de Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron 2016;22:348-64.
Mason MG, Nicholls P, Cooper CE. Re-evaluation of the near infrared spectra of mitochondrial cytochrome c oxidase: Implications for non invasive in vivo monitoring of tissues. Biochim Biophys Acta 2014;1837:1882-1891.
Stryer L. Biochemistry. 4th Edition ed: Freeman and Company; 1995.
Sousa KB dSAL, Pedroso NM. Photobiomodulation effects on gene and protein expression of proinflammatory chemokines and cytokines by J774 macrophages polarized to M1 phenotype. Lasers Surg Med 2017.
de Brito Sousa K, Rodrigues MFSD, de Souza Santos D, Mesquita-Ferrari RA, Nunes FD, de Fátima Teixeira da Silva D, et al. Differential expression of inflammatory and anti-inflammatory mediators by M1 and M2 macrophages after photobiomodulation with red or infrared lasers. Lasers Med Sci 2020;35:337-43.
Jahani Sherafat S, Mokmeli S, Rostami-Nejad M, Razaghi Z, Tavirani MR, Razzaghi M. The Effectiveness of Photobiomudulation Therapy (PBMT) in COVID-19 Infection. J Lasers Med Sci 2020;11:23.
Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS biophys 2017;4:337.
Schindl A, Schindl M, Pernerstorfer-Schön H, Schindl L. Low-intensity laser therapy: a review. J Investig Med 2000;4:337-361.
Langella LG, Casalechi HL, Tomazoni SS, Johnson DS, Albertini R, Pallotta RC, et al. Photobiomodulation therapy (PBMT) on acute pain and inflammation in patients who underwent total hip arthroplasty—a randomized, triple-blind, placebo-controlled clinical trial. Lasers Med Sci 2018;33:1933-40.
Liebert A, Bicknell B, Laakso E-L, Heller G, Jalilitabaei P, Tilley S, et al. Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study. BMC Neurol 2021;21:1-15.
Chen Q, Wu J, Dong X, Yin H, Shi X, Su S, et al. Gut flora-targeted photobiomodulation therapy improves senile dementia in an Aß-induced Alzheimer’s disease animal model. J Photochem Photobiol B, Biol 2021;216:112152.
Rostami Nejad M, Ishaq S, Al Dulaimi D, Zali MR, Rostami K. The role of infectious mediators and gut microbiome in the pathogenesis of celiac disease. Arch Iran Med 2015;18:244-9.
De Marchi T, Ferlito JV, Ferlito MV, Salvador M, Leal-Junior EC. Can Photobiomodulation Therapy (PBMT) minimize exercise-induced oxidative stress? a systematic review and meta-analysis. Antioxidants 2022;11:1671.
Chen H, Cai Y, Sun S, Pan Z, Han Z, Liu P, et al. Repair effect of photobiomodulation combined with human umbilical cord mesenchymal stem cells on rats with acute lung injury. J Photochem Photobiol B, Biol 2022;234:112541.
Anju M, Chacko L, Chettupalli Y, Maiya AG, Saleena Ummer V. Effect of Low Level Laser Therapy on serum vitamin D and magnesium levels in patients with diabetic peripheral neuropathy – A pilot study. Diabetes Metab Syndr 2019;13:1087-91.
Singh P, Rawat A, Alwakeel M, Sharif E, Al Khodor S. The potential role of vitamin D supplementation as a gut microbiota modifier in healthy individuals. Sci Rep 2020;10:21641.
Thaiss CA, Zeevi D, Levy M, Segal E, Elinav E. A day in the life of the meta-organism: diurnal rhythms of the intestinal microbiome and its host. Gut Microbes 2015;6:137-42.
Leone V, Gibbons SM, Martinez K, Hutchison AL, Huang EY, Cham CM, et al. Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe 2015;17:681-9.
Agababova A, Movsesyan H. Change of gut microflora of healthy rats under the low energy laser irradiation. Dokl Akad Nauk SSSR 2011;111:372-8.
De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms 2021;9.
Liebert A, Bicknell B, Laakso E-L, Jalilitabaei P, Tilley S, Kiat H, et al. Remote photobiomodulation treatment for the clinical signs of Parkinson’s disease: a case series conducted during COVID-19. Photobiomodul Photomed Laser Surg 2022;40:112-22.
De Menezes BC, Thebit MM, Bonela LAS, De Oliveira KG, Gonçalves WL, Bissoli NS, et al. Laser therapy as a preventive approach for oral mucositis in cancer patients undergoing chemotherapy: the potential role of superoxide dismutase. Asian Pac J Cancer Prev 2021;22:3211.
Hsieh YL, Chou LW, Hong SF, Chang FC, Tseng SW, Huang CC, et al. Laser acupuncture attenuates oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: a pilot prospective cohort study. Acupunct Med 2016;34:398-405.
- Abstract Viewed: 385 times
- PDF Downloaded: 364 times